Veterinary Breakroom: The Rise of Monoclonal Antibodies in Vet Med

Welcome to the Veterinary Breakroom! Join Alyssa Watson, DVM, and Beth Molleson, DVM, as they discuss pressing issues impacting the veterinary profession, including why monoclonal antibody therapies are poised to become one of the most important drug classes in both human and veterinary medicine. In this episode, they explore the mAbs already available in practice, where the pipeline is heading, and why staying informed matters for busy clinicians who want to be prepared for the next wave of therapeutic innovation.Contact:[email protected] To Find Us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/Instagram: @Clinicians.BriefX: @CliniciansBriefThe Team:Alyssa Watson, DVM - HostBeth Molleson, DVM - HostAlexis Ussery - Producer & Multimedia SpecialistDisclaimer: This podcast recording represents the opinions of Dr. Alyssa Watson and Dr. Beth Molleson. Content is presented for discussion purposes and should not be taken as medical advice. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast.

Welcome to the Veterinary Breakroom! Join Alyssa Watson, DVM, and Beth Molleson, DVM, as they discuss pressing issues impacting the veterinary profession. A recent case involving a veterinarian intervening in a perceived neglect situation sparked a larger conversation about the moral and ethical dilemmas veterinarians face every day. Tune in for an exploration of the gray areas where compassion, professional duty, and the law intersect—asking tough questions about what it really means to “do the right thing” in veterinary medicine.Resources:https://apnews.com/article/veterinarian-charged-homeless-man-dog-fc66ca92499cc3bc90faf7abb3e7f2d0https://apnews.com/article/veterinarian-theft-homeless-dog-7d5fadb5fab879e5ef777539b1b5220dhttps://www.yahoo.com/news/articles/veterinarian-found-guilty-stealing-dog-224850610.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAEJwjHQRSljgPhMAEl7DTITaMtG3Bgfp4YmxRrbqkGLMKIEOYxNrLqanYEG-BT-dj0wH5f5SBIjfCsWiSasNHWO2f285PTiLnV-rbzv2fgCviY1XdIY77tUZF2TO_cV23ezbSD6HJQ9AT_sSXbrGPXVslMZ-2KwJ5TvqPIGtSJjYhttps://www.avma.org/resources-tools/animal-health-and-welfare/animal-welfare/responding-to-suspected-animal-cruelty-maltreatmentContact:[email protected] To Find Us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/Instagram: @Clinicians.BriefX: @CliniciansBriefThe Team:Alyssa Watson, DVM - HostBeth Molleson, DVM - HostAlexis Ussery - Producer & Multimedia SpecialistDisclaimer: This podcast recording represents the opinions of Dr. Alyssa Watson and Dr. Beth Molleson. Content is presented for discussion purposes and should not be taken as medical advice. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast.

NSAIDs have long been the cornerstone of pharmaceutical pain relief for dogs with OA. But with the arrival of an OA monoclonal antibody therapy, is it time to rethink our approach? In this episode of Clinician’s Brief Partner Podcast, Dr. Beth invites renowned orthopedic expert Dr. John Innes to discuss how he approaches OA management, drawing from >4 years of experience with bedinvetmab in the United Kingdom. They also dive into a head-to-head study comparing bedinvetmab with an NSAID and explore what the findings mean for today’s treatment strategies.  Sponsored by Zoetis Contact us:[email protected] to find us:Cliniciansbrief.com/podcastsFacebook.com/clinciansbriefTwitter: @cliniciansbriefInstagram: @clinicians.briefThe Team:Beth Molleson, DVM - HostSarah Pate - Producer & Project Manager, Brief StudioTaylor Argo - Podcast Production & Sound EditingLIBRELA IMPORTANT SAFETY INFORMATION: For use in dogs only. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid selfinjection. Hypersensitivity reactions, including anaphylaxis, could potentially occur with self-injection. Librela should not be used in breeding, pregnant or lactating dogs. Librela should not be administered to dogs with known hypersensitivity to bedinvetmab. The most common adverse events reported in a clinical study were urinary tract infections, bacterial skin infections and dermatitis. See full Prescribing Information at LibrelaPI.com

In this episode, host Alyssa Watson, DVM, welcomes Jake Wolf, DVM, DACVECC, to discuss his recent Clinician’s Brief article, “Top 7 Updates for Veterinary Cardiopulmonary Resuscitation.” Dr. Wolf, one of the authors for the 2024 RECOVER guidelines update, reviews the important changes covered in the update, including compressions, capnography, epinephrine dosing. He also shares how we can all implement them in practice.Resources:https://cliniciansbrief.com/article/veterinary-cpr-updates-2024https://solensiavetteam.comContact:[email protected] To Find Us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/Instagram: @Clinicians.BriefX: @CliniciansBriefThe Team:Alyssa Watson, DVM - HostAlexis Ussery - Producer & Multimedia Specialist

When it comes to chronic kidney disease, early detection and whole-body support can make all the difference. In episode of the Partner Podcast, Dr. Beth talks with Dr. Nicole Sheehan about how nutrition, inflammation control, and cellular support tools like protomorphogens can fit into a multimodal plan for kidney patients. Tune in as they discuss how integrative medicine can transform the way we support renal health in our patients.Sponsored by Standard ProcessResource:https://www.standardprocess.com/products/canine-renal-supporthttps://www.standardprocess.com/products/feline-renal-supportContact us:[email protected] to find us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/X: @cliniciansbriefInstagram: @clinicians.briefThe Team:Beth Molleson, DVM - HostTaylor Argo- Producer, Sound Editing, & Project Manager, Brief StudioReferences: Khan MA, Kassianos AJ, Hoy WE, Alam AK, Healy HG, Gobe GC. Promoting plant-based therapies for chronic kidney disease. J Evid Based Integr Med. 2022;27:2515690X221079688. doi:10.1177/2515690X221079688Hall JA, Fritsch DA, Jewell DE, Burris PA, Gross KL. Cats with IRIS stage 1 and 2 chronic kidney disease maintain body weight and lean muscle mass when fed food having increased caloric density, and enhanced concentrations of carnitine and essential amino acids. Vet Rec. 2019;184(6):190. doi:10.1136/vr.104865Raj D, Tomar B, Lahiri A, Mulay SR. The gut-liver-kidney axis: novel regulator of fatty liver associated chronic kidney disease. Pharmacol Res. 2020;152:104617. doi:10.1016/j.phrs.2019.104617Kobayashi S, Kawarasaki M, Aono A, Cho J, Hashimoto T, Sato R. Renoprotective effects of docosahexaenoic acid in cats with early chronic kidney disease due to polycystic kidney disease: a pilot study. J Feline Med Surg. 2022;24(12):e505-e512. doi:10.1177/1098612X221136815Jun M, Venkataraman V, Razavian M, et al. Antioxidants for chronic kidney disease. Cochrane Database Syst Rev. 2012;10(10):CD008176. doi:10.1002/14651858.CD008176.pub2

Welcome to the Veterinary Breakroom! Join Alyssa Watson, DVM, and Beth Molleson, DVM, as they discuss pressing issues impacting the veterinary profession. In this episode, they sit down to explore the potential benefits, challenges, and real-world applications of “wait-and-see prescriptions” (WASPs) for pets, and what veterinarians should consider before trying it in practice.Resources:https://jamanetwork.com/journals/jama/fullarticle/203330https://solensiavetteam.comContact:[email protected] To Find Us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/Instagram: @Clinicians.BriefX: @CliniciansBriefThe Team:Alyssa Watson, DVM - HostBeth Molleson, DVM - HostAlexis Ussery - Producer & Multimedia SpecialistDisclaimer: This podcast recording represents the opinions of Dr. Alyssa Watson and Dr. Beth Molleson. Content is presented for discussion purposes and should not be taken as medical advice. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast.

When a cat is presented with acute dyspnea, differentiating heart from lung disease isn’t just important—it’s imperative. In this episode of the Partner Podcast, we sit down with Dr. Paul Zoyhofski to explore practical approaches for distinguishing cardiac from primary respiratory disease during feline emergencies. From physical examination cues to point-of-care biomarkers like NT-proBNP, get expert insights into making faster, more confident treatment decisions.Sponsored by BionoteContact us:[email protected] to find us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/X: @cliniciansbriefInstagram: @clinicians.briefThe Team:Beth Molleson, DVM - HostSarah Pate - Producer & Project Manager, Brief StudioTaylor Argo- Podcast Production & Sound Editing

In this episode, host Alyssa Watson, DVM, is joined by Theresa E. Pancotto, DVM, MS, DACVIM (Neurology), CCRP, to talk about her recent Clinician’s Brief article, “Traumatic Brain Injury in a Dog.” Dr. Pancotto delivers point after point of useful information for diagnosing TBI, assessing severity, and providing the most effective therapies.Resource:https://www.cliniciansbrief.com/article/tbi-dog-treatment-quizContact:[email protected] To Find Us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/Instagram: @Clinicians.BriefX: @CliniciansBriefThe Team:Alyssa Watson, DVM - HostAlexis Ussery - Producer & Multimedia Specialist

When a cat is diagnosed with hypertrophic cardiomyopathy (HCM), the path forward often feels uncertain, but this innovative development in the treatment of feline HCM is changing the game and carving out clearer treatment paths. In this episode of the Partner Podcast, Dr. Ashlie Saffire explores how a new targeted treatment, Felycin-CA1, may transform not only how veterinarians manage this common feline heart disease but also how we think about screening for subclinical HCM in practice.Sponsored by PRN PharmacalResource:Felycin.comContact us:[email protected] to find us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/X: @cliniciansbriefInstagram: @clinicians.briefThe Team:Beth Molleson, DVM - HostTaylor Argo- Producer, Sound Editing, & Project Manager, Brief Studio

Welcome to the Veterinary Breakroom! Join Alyssa Watson, DVM, and Beth Molleson, DVM, as they discuss pressing issues impacting the veterinary profession. In this episode, they explore the declining role of terminal surgery labs in veterinary education while reflecting on their own training experiences with and without this practice. From advances in simulation technology to the ethical considerations of live animal use, they weigh the benefits and limitations of different teaching approaches. Tune in for a thoughtful conversation about how the next generation of veterinarians are learning critical surgical skills.Resources:https://news.vin.com/default.aspx?pid=210&Id=12825847https://news.vin.com/default.aspx?pid=210&Id=12834885&f5=1https://solensiavetteam.comContact:[email protected] To Find Us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/Instagram: @Clinicians.BriefX: @CliniciansBriefThe Team:Alyssa Watson, DVM - HostBeth Molleson, DVM - HostAlexis Ussery - Producer & Multimedia SpecialistDisclaimer: This podcast recording represents the opinions of Dr. Alyssa Watson and Dr. Beth Molleson. Content is presented for discussion purposes and should not be taken as medical advice. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast.